Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
261.09(c) 262.85(c) 269.42(c) 286.36(c) 278.34(c) Last
2 011 888 3 854 495 2 029 221 2 558 793 3 542 012 Volume
+5.41% +0.67% +2.50% +6.29% -2.80% Change
More quotes
Estimated financial data (e)
Sales 2021 16 703 M 19 447 M 19 447 M
Net income 2021 8 797 M 10 242 M 10 242 M
Net cash position 2021 8 661 M 10 084 M 10 084 M
P/E ratio 2021 6,80x
Yield 2021 -
Sales 2022 16 697 M 19 441 M 19 441 M
Net income 2022 9 328 M 10 861 M 10 861 M
Net cash position 2022 18 931 M 22 041 M 22 041 M
P/E ratio 2022 6,61x
Yield 2022 -
Capitalization 57 719 M 67 225 M 67 202 M
EV / Sales 2021 2,94x
EV / Sales 2022 2,32x
Nbr of Employees 2 500
Free-Float 87,3%
More Financials
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer... 
More about the company
Ratings of BioNTech SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BIONTECH SE
10/22Health Care Up On Defensive Bias -- Health Care Roundup
DJ
10/22MODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines ma..
RE
10/22Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
RE
10/22PFIZER : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Eff..
MT
10/22European ADRs Move Higher in Friday Trading
MT
10/22PFIZER : Norway Stops Second Dose COVID-19 Vaccine Inoculations For Minors
MT
10/22PFIZER : BioNTech COVID-19 Vaccine Shows Nearly 91% Efficacy in Kids
MT
10/22BIONTECH : Deutsche Bank Starts BioNTech at Hold with $250 Price Target
MT
10/22PFIZER : BioNTech COVID Vaccine Reportedly Shows Nearly 91% Efficacy in Kids
MT
10/21Health Care Up As BioNTech Rallies -- Health Care Roundup
DJ
10/21PFIZER WILL SHIP MILLIONS OF VACCINE : Trudeau
AQ
10/21BIONTECH : Shares Rise After Data Shows Efficacy of COVID-19 Vaccine's Booster Dose
MT
10/21GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
10/21Canada, Pfizer Strike Deal on Pediatric Vaccine Doses
DJ
10/21European ADRs Move Lower in Thursday Trading
MT
More news
News in other languages on BIONTECH SE
10/23Vaccin Pfizer voldoet aan criteria FDA voor immuunrespons jonge kinderen
10/22Le comité de la FDA votera sur les vaccins COVID-19 de Pfizer destinés aux enfants ; le..
10/22CORONA-BLOG/Biontech-Impfstoff bei Kindern zu knapp 91% wirksam
10/22Les ADR européens sont en hausse vendredi
10/22COVID : Pfizer revendique une efficacité de 90% pour le vaccin chez les 5-11 ans
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 238,98 €
Average target price 254,57 €
Spread / Average Target 6,52%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE241.44%67 225
GILEAD SCIENCES, INC.15.41%84 306
WUXI APPTEC CO., LTD.24.51%64 578
REGENERON PHARMACEUTICALS18.47%59 507
VERTEX PHARMACEUTICALS-22.35%47 610
BEIGENE, LTD.46.63%35 360